- Additional Authors
- Description
- 18 pages : digital, PDF file
- Alternative Title
- New contrast imaging indication considerations for devices and approved drug and biological products
- Subject
- Note
- Title from PDF title page (viewed on Apr. 6, 2009).
- "Draft guidance."
- "September 2008."
- System Details (note)
- Mode of access: Internet at the FDA CBER web site. Address as of 4/06/09: http://www.fda.gov/oc/combination/contrastimg.pdf ; current access is available via PURL.
- Call Number
- GPO Internet HE 20.4002:C 74
- OCLC
- marcive317882445
- Title
Guidance for industry : new contrast imaging indication considerations for devices and approved drug and biological products.
- Publisher
Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Office of Combination Products (OCP) in Office of Commissioner : Center for Devices and Radiological Health (CDRH) : Center for Drug Evaluation and Research (CDER), [2008]
- Type of Content
text
- Type of Medium
computer
- Type of Carrier
online resource
- System Details
Mode of access: Internet at the FDA CBER web site. Address as of 4/06/09: http://www.fda.gov/oc/combination/contrastimg.pdf ; current access is available via PURL.
- Connect to:
- Added Author
United States. Food and Drug Administration. Office of Combination Products.
Center for Devices and Radiological Health (U.S.)
Center for Drug Evaluation and Research (U.S.)
- Gpo Item No.
0475 (online)
- Sudoc No.
HE 20.4002:C 74 HE 20.4802:C 74